Flavonoids Biotransformation by Human Gut Bacterium Dorea sp. MRG-IFC3 Cell-Free Extract
Human gut bacterium sp. MRG-IFC3 is unique in that it is capable of metabolizing puerarin, an isoflavone -glycoside, whereas it shows broad substrate glycosidase activity for the various flavonoid -glycosides. To address the question on the substrate specificity, as well as biochemical characteristi...
Gespeichert in:
Veröffentlicht in: | Journal of microbiology and biotechnology 2024, 34(6), , pp.1270-1275 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Human gut bacterium
sp. MRG-IFC3 is unique in that it is capable of metabolizing puerarin, an isoflavone
-glycoside, whereas it shows broad substrate glycosidase activity for the various flavonoid
-glycosides. To address the question on the substrate specificity, as well as biochemical characteristics, cell-free biotransformation of flavonoid glycosides was performed under various conditions. The results showed that there are two different enzyme systems responsible for the metabolism of flavonoid
-glycosides and
-glycosides in the MRG-IFC3 strain. The system responsible for the conversion of puerarin was inducible and comprised of two enzymes. One enzyme oxidizes puerarin to 3"-oxo-puerarin and the other enzyme converts 3"-oxo-puearin to daidzein. The second enzyme was only active toward 3"-oxo-puerarin. The activity of puerarin conversion to daidzein was enhanced in the presence of Mn
and NAD
. It was concluded that the puerarin
-deglycosylation by
sp. MRG-IFC3 possibly adopts the same biochemical mechanism as the strain PUE, a species of
. |
---|---|
ISSN: | 1017-7825 1738-8872 |
DOI: | 10.4014/jmb.2403.03058 |